Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125873691 | 12587369 | 1 | I | 2006 | 20120524 | 20160725 | 20160725 | EXP | US-ASTRAZENECA-2012SE33899 | ASTRAZENECA | 53.00 | YR | M | Y | 0.00000 | 20160725 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125873691 | 12587369 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 40 | MG | TABLET | QD | |||||||
125873691 | 12587369 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | TABLET | ||||||||||
125873691 | 12587369 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
125873691 | 12587369 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
125873691 | 12587369 | 5 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
125873691 | 12587369 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | 0 | 81 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125873691 | 12587369 | 1 | Blood cholesterol abnormal |
125873691 | 12587369 | 2 | Blood cholesterol abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125873691 | 12587369 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125873691 | 12587369 | Atrial fibrillation | |
125873691 | 12587369 | Body height decreased | |
125873691 | 12587369 | Calcinosis | |
125873691 | 12587369 | Chest pain | |
125873691 | 12587369 | Depression | |
125873691 | 12587369 | Drug dose omission | |
125873691 | 12587369 | Dyspnoea | |
125873691 | 12587369 | Fatigue | |
125873691 | 12587369 | Feeling abnormal | |
125873691 | 12587369 | Gastrointestinal disorder | |
125873691 | 12587369 | Heat exhaustion | |
125873691 | 12587369 | Intentional product misuse | |
125873691 | 12587369 | Lactose intolerance | |
125873691 | 12587369 | Panic attack | |
125873691 | 12587369 | Stress | |
125873691 | 12587369 | Thyroid mass | |
125873691 | 12587369 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125873691 | 12587369 | 1 | 2003 | 201307 | 0 |